ONCAlert | 2018 SGO Annual Meeting on Women’s Cancer

Toxicities Associated With PI3K Inhibitors

Denise A. Yardley, MD
Published Online: 8:52 PM, Thu December 11, 2014
Denise A. Yardley, MD, from Sarah Cannon Research Institute, discusses toxicities associated with treatment with PI3K inhibitors for breast cancer.

<<< Go back to the SABCS conference page

Copyright © TargetedOnc 2018 Intellisphere, LLC. All Rights Reserved.